Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solomon Tesfaye

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|April 30, 2026
Expert considerations to guide the development and delivery of an exercise intervention in people with type 2 diabetes-related foot ulcer diseaseVicki L Johnson, Vicky Hall, Rachel Berrington, et al.
Pain Reports|June 21, 2018
Neuropathic pain drives anxiety behavior in mice, results consistent with anxiety levels in diabetic neuropathy patientsChristine B Sieberg, Caitlin Taras, Aya Gomaa, et al.
Diabetes Research and Clinical Practice|March 21, 2025
Serum Neurofilament Light Chain and Structural and Functional Nerve Fiber Loss in Painful and Painless Diabetic PolyneuropathyLaura L Määttä, Signe T Andersen, Tina Parkner, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 5, 2025
A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi-centre randomised control trial (MiFoot study)Tolu Onuwe, Patrick J Highton, David Batchelor, et al.
Muscle & Nerve|July 27, 2010
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Archives of Neurology|September 19, 2012
"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys TrialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Health Technology Assessment (Winchester, England)|October 19, 2022
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCTSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Pain|June 9, 2017
Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendationsJan Vollert, Christoph Maier, Nadine Attal, et al.
Lancet (London, England)|August 25, 2022
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trialSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Cardiovascular Diabetology|March 20, 2024
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomesOliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Diabetic Medicine : a Journal of the British Diabetic Association|April 30, 2026
Expert considerations to guide the development and delivery of an exercise intervention in people with type 2 diabetes-related foot ulcer diseaseVicki L Johnson, Vicky Hall, Rachel Berrington, et al.
Pain Reports|June 21, 2018
Neuropathic pain drives anxiety behavior in mice, results consistent with anxiety levels in diabetic neuropathy patientsChristine B Sieberg, Caitlin Taras, Aya Gomaa, et al.
Diabetes Research and Clinical Practice|March 21, 2025
Serum Neurofilament Light Chain and Structural and Functional Nerve Fiber Loss in Painful and Painless Diabetic PolyneuropathyLaura L Määttä, Signe T Andersen, Tina Parkner, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 5, 2025
A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi-centre randomised control trial (MiFoot study)Tolu Onuwe, Patrick J Highton, David Batchelor, et al.
Muscle & Nerve|July 27, 2010
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Archives of Neurology|September 19, 2012
"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys TrialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Health Technology Assessment (Winchester, England)|October 19, 2022
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCTSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Pain|June 9, 2017
Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendationsJan Vollert, Christoph Maier, Nadine Attal, et al.
Lancet (London, England)|August 25, 2022
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trialSolomon Tesfaye, Gordon Sloan, Jennifer Petrie, et al.
Cardiovascular Diabetology|March 20, 2024
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomesOliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, et al.
Pageof 16